tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Milestone Pharmaceuticals upgraded to Buy at TD Cowen after Cardamyst approval
PremiumThe FlyMilestone Pharmaceuticals upgraded to Buy at TD Cowen after Cardamyst approval
1M ago
Milestone Pharmaceuticals upgraded to Buy from Hold at TD Cowen
Premium
The Fly
Milestone Pharmaceuticals upgraded to Buy from Hold at TD Cowen
1M ago
Milestone Pharmaceuticals Poised for Success with Cardamyst Approval and Strong Market Potential
Premium
Ratings
Milestone Pharmaceuticals Poised for Success with Cardamyst Approval and Strong Market Potential
1M ago
Milestone Pharmaceuticals: Buy Rating Reaffirmed Amid Imminent PDUFA Date and Misunderstood CRL Implications
PremiumRatingsMilestone Pharmaceuticals: Buy Rating Reaffirmed Amid Imminent PDUFA Date and Misunderstood CRL Implications
1M ago
Milestone Pharmaceuticals Reports Q3 2025 Financial Results
Premium
Company Announcements
Milestone Pharmaceuticals Reports Q3 2025 Financial Results
2M ago
Milestone Pharmaceuticals Prepares for CARDAMYST Launch Amid Financial Growth
Premium
Company Announcements
Milestone Pharmaceuticals Prepares for CARDAMYST Launch Amid Financial Growth
2M ago
Milestone Pharmaceuticals initiated with an Overweight at Wells Fargo
PremiumThe FlyMilestone Pharmaceuticals initiated with an Overweight at Wells Fargo
4M ago
Milestone Pharmaceuticals Reports Increased Loss Amid R&D Focus
Premium
Company Announcements
Milestone Pharmaceuticals Reports Increased Loss Amid R&D Focus
5M ago
Milestone Pharmaceuticals: Strong Buy Rating Backed by Anticipated Cardamyst Approval and Robust Financial Position
Premium
Ratings
Milestone Pharmaceuticals: Strong Buy Rating Backed by Anticipated Cardamyst Approval and Robust Financial Position
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100